Shopping Cart 0
Cart Subtotal
AED 0

BioRestorative Therapies Inc (BRTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 918

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 1835

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 2753

Details

Summary

BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment for chronic lumbar disc diseases such as bulging and herniated discs. Its ThermoStem program develops brown fat stem cell-based therapy which is used for the treatment of type 2 diabetes, obesity, and other metabolic disorders. BRT provides identification and treatment of first stem cell population isolated from a particular brown fat depot in humans. The company operates in the US. BRT is headquartered in Melville, New York, the US.

BioRestorative Therapies Inc (BRTX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 11

BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 12

BioRestorative Therapies Enters into Research Agreement with Pfizer 13

BioRestorative Therapies Enters Into R&D Agreement With Rohto Pharma 14

BioRestorative Therapies Enters into Agreement with Japanese pharma 15

BioRestorative Therapies Enters Into Research Agreement With University of Utah 16

Licensing Agreements 17

BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 17

Equity Offering 18

BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 18

BioRestorative Therapies to Raise up to USD4 Million in Public Offering of Shares and Warrants 19

BioRestorative Therapies Completes Private Placement Of Shares For USD 0.5 Million 21

Debt Offering 22

BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 22

BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 23

BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 24

BioRestorative Therapies Inc-Key Competitors 25

BioRestorative Therapies Inc-Key Employees 26

BioRestorative Therapies Inc-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Corporate Communications 28

Jul 25, 2018: BioRestorative Therapies Appoints Jason M. Lipetz to its Scientific Advisory Board 28

Jan 22, 2018: BioRestorative Therapies Appoints Adam D. Bergstein as Senior Vice President, Planning and Business Development 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioRestorative Therapies Inc, Deals By Therapy Area, 2012 to YTD 2018 8

BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 11

BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 12

BioRestorative Therapies Enters into Research Agreement with Pfizer 13

BioRestorative Therapies Enters Into R&D Agreement With Rohto Pharma 14

BioRestorative Therapies Enters into Agreement with Japanese pharma 15

BioRestorative Therapies Enters Into Research Agreement With University of Utah 16

BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 17

BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 18

BioRestorative Therapies to Raise up to USD4 Million in Public Offering of Shares and Warrants 19

BioRestorative Therapies Completes Private Placement Of Shares For USD 0.5 Million 21

BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 22

BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 23

BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 24

BioRestorative Therapies Inc, Key Competitors 25

BioRestorative Therapies Inc, Key Employees 26

BioRestorative Therapies Inc, Subsidiaries 27

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

BioRestorative Therapies Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

BioRestorative Therapies Inc (BRT), formerly Stem Cell Assurance Inc is a developer of therapeutic products and medical therapies. The company performs stem cell programs which include brtxDISC and ThermoStem. brtxDISC,a lead therapeutic product, is designed to offer a non-surgical treatment for chronic lumbar disc diseases such as bulging and herniated discs. Its ThermoStem program develops brown fat stem cell-based therapy which is used for the treatment of type 2 diabetes, obesity, and other metabolic disorders. BRT provides identification and treatment of first stem cell population isolated from a particular brown fat depot in humans. The company operates in the US. BRT is headquartered in Melville, New York, the US.

BioRestorative Therapies Inc (BRTX)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 11

BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 12

BioRestorative Therapies Enters into Research Agreement with Pfizer 13

BioRestorative Therapies Enters Into R&D Agreement With Rohto Pharma 14

BioRestorative Therapies Enters into Agreement with Japanese pharma 15

BioRestorative Therapies Enters Into Research Agreement With University of Utah 16

Licensing Agreements 17

BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 17

Equity Offering 18

BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 18

BioRestorative Therapies to Raise up to USD4 Million in Public Offering of Shares and Warrants 19

BioRestorative Therapies Completes Private Placement Of Shares For USD 0.5 Million 21

Debt Offering 22

BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 22

BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 23

BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 24

BioRestorative Therapies Inc-Key Competitors 25

BioRestorative Therapies Inc-Key Employees 26

BioRestorative Therapies Inc-Locations And Subsidiaries 27

Head Office 27

Other Locations & Subsidiaries 27

Recent Developments 28

Corporate Communications 28

Jul 25, 2018: BioRestorative Therapies Appoints Jason M. Lipetz to its Scientific Advisory Board 28

Jan 22, 2018: BioRestorative Therapies Appoints Adam D. Bergstein as Senior Vice President, Planning and Business Development 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30


List Of Figure

List of Figures

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9


List Of Table

List of Tables

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

BioRestorative Therapies Inc, Deals By Therapy Area, 2012 to YTD 2018 8

BioRestorative Therapies Inc, Medical Devices Deals, 2012 to YTD 2018 9

BioRestorative Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 11

BioRestorative Therapies Enters into Research Agreement with University of Pennsylvania 12

BioRestorative Therapies Enters into Research Agreement with Pfizer 13

BioRestorative Therapies Enters Into R&D Agreement With Rohto Pharma 14

BioRestorative Therapies Enters into Agreement with Japanese pharma 15

BioRestorative Therapies Enters Into Research Agreement With University of Utah 16

BioRestorative Therapies Enters Into Licensing Agreement With Regenerative Sciences For Stem Cell Disc And Spine Procedure 17

BioRestorative Therapies Files Registration Statement for Public Offering of Shares and Warrants for up to USD15 Million 18

BioRestorative Therapies to Raise up to USD4 Million in Public Offering of Shares and Warrants 19

BioRestorative Therapies Completes Private Placement Of Shares For USD 0.5 Million 21

BioRestorative Therapies Raises USD0.2 Million in Private Placement of 8% Note Due 2017 22

BioRestorative Therapies Raises USD0.24 Million in Private Placement of 8% Note Due 2017 23

BioRestorative Therapies Raises USD0.21 Million in Private Placement of 8% Note Due 2017 24

BioRestorative Therapies Inc, Key Competitors 25

BioRestorative Therapies Inc, Key Employees 26

BioRestorative Therapies Inc, Subsidiaries 27

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

BioRestorative Therapies Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.